CSI Market
Sign In | Register

Blueprint Medicines (BPMC) Annual Balance Sheets

Annual · GAAP · USD millions
Access BPMC quarterly Balance Sheets →
This page allows investors to track Blueprint Medicines's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Assets
Cash & cash equivalent102.01
Combined Cash+Investments Total (filer-reported)863.90
Available-for-sale Securities, Debt Securities, Current MA513.47
Cash & Short-term Investments615.00
Accounts receivable75.80
Inventories13.61
Other Current Assets1.81
Prepaid Expense And Other Assets Current35.97
Total Current Assets742.68
Equipment/Property/Plant Net36.59
Long-term investments248.45
Other Assets, Noncurrent78.00
Unbilled Receivables Including Reimbursable Costs Current1.81
Operating Lease Right Of Use Asset64.18
Restricted Cash Noncurrent11.63
Total Assets1,179.81
Liabilities
Accounts Payable, Current AC6.79
Accrued Liabilities, Current AC133.09
Secured Debt, Current LO43.92
Other Liabilities, Current77.00
Total Current Liabilities260.80
Long-term debt343.05
Secured Debt343.05
Capital Lease and Other61.65
Total Long-term Debt404.70
Other liabilities, Noncurrent215.65
Contract With Customer Liability Current2.01
Operating Lease Liability Noncurrent68.79
Contract With Customer Liability Noncurrent8.19
Total Liabilities881.15
Stockholders' Equity
Common Stock Value0.06
Additional Paid In Capital Common Stock2,709.18
Retained Earnings / Accumulated Deficit-2,407.03
Other Equity-3.55
Common Stockholder's Equity298.67
Total Stockholder's Equity298.67
Liabilities & Stockholder's Equity1,179.81
4 historic quarters locked

Sign in to unlock the full Blueprint Medicines balance sheet history.

Sign In Create Free Account

About Blueprint Medicines Corp Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001558370-25-000953

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License